Volume : 09, Issue : 12, December – 2022

Title:

22.DEVELOPMENT OF NEW RP-HPLC METHOD FOR THE ESTIMATION OF BETAMETHASONE AND CALCIPOTRIENE IN THE OINTMENT DOSAGE FORM AND VALIDATION OF THE DEVELOPED METHOD.

Authors :

Azmanur Rahman, Shahajul Islam, MD. Salma sulthana, Mamidi upendar

Abstract :

Combination therapy of calcipotriol monohydrate (CPM) and betamethasone dipropionate (BMD) is the option of choice for treatment of psoriasis. Psoriatic patients suffer from chronic dermatitis characterized by scaling, infiltration and erythema. The presant work is aimed at developing a validated RP-HPLC method for the simultaneous estimation of calcipotriol monohydrate (CPM) and betamethasone dipropionate (BMD) by using most affordable materials and techniques. Initially the mobile phase tried was methanol: Ortho phosphoric acid buffer and Methanol: phosphate buffer, Acetonitrile: methanol with various combinations of pH as well as varying proportions. Finally, the mobile phase was optimized to Phosphate buffer (pH 3.0), Ethanol in proportion 45 : 55 v/v respectively. The method was performed with various columns like C18 column Phenomenex column, YMC, and Inertsil ODS column. Dikma Endeversil C18 ODS (2.1x 150mm, 3 m) was found to be ideal as it gave good peak shape and resolution at 0.3 ml/min flow and the retention times were found to be 3.724, 5.148min.. UV spectrum of 10 µg/ml Betamethasone and 10 µg/ml Calcipotriene in diluents (mobile phase composition) was recorded by scanning in the range of 1000nm to 400nm. From the UV spectrum wavelength selected as 254 nm. At this wavelength both the drugs show good absorbance. The method developed was subjected to system suitability, assay (betamethasone dipropionate-99.97%, calcipotriol monohydrate100.64%). Precision, accuracy, robustness LOD, LOQ and degradation studies and found the results are within limits.
Keywords: betamethasone dipropionate, calcipotriol monohydrate, Acetonitrile, psoriasis etc.

Cite This Article:

Please cite this article in press Azmanur Rahman et al, Development Of New RP-HPLC Method For The Estimation Of Betamethasone And Calcipotriene In The Ointment Dosage Form And Validation Of The Developed Method., Indo Am. J. P. Sci, 2022; 09(12).

Number of Downloads : 10

References:

1. Willard H. H., Merit L.L., Dean F.A., and Settle F.A., “Instrumental Methods of Analysis.”, C.B. S. Publishers, New Delhi, 7th edition, 2002, 580-613
2. Skoog D.A., Holler F.J., Nieman T.A., “ Principles of Instrumental Analysis.”, 5th edition, 2005, 733-738.
3. Sharma B.K., “Instrumental Methods of Chemical Analysis.”, Goel Publishing House, Meerut, 24th edition, 2005, C-210-215..
4. SHANKAR L. TURWALE, RAJESH K. DWIVEDI and MADHUSUDAN T. BACHUTE, Development of Fast Reverse Phase Liquid Chromatographic Method for Simultaneous Analysis of Betamethasone Dipropionate and Calcipotriol in Ointments and Bulk Drug, Asian Journal of Chemistry; Vol. 26, No. 19 (2014), 6465-6468.
5. Swapna, B. & Gangarapu, Kiran & Vasudha, B. & Kumar, Rajendra. (2018). Stability indicating RP-HPLC method for simultaneous estimation of betamethasone dipropionate and calcipotriene in bulk and pharmaceutical dosage form. Biointerface Research in Applied Chemistry. 8. 3089-3094.
6. Hanan A Merey, Sally S El-Mosallamy, Nagiba Y Hassan, Badr A El-Zeany, Validated Chromatographic Methods for Simultaneous Determination of Calcipotriol Monohydrate and Betamethasone Dipropionate in the Presence of Two Dosage Form Additives, Journal of Chromatographic Science, Volume 57, Issue 4, April 2019, Pages 305–311, https://doi.org/10.1093/chromsci/bmy112.
7. Sonia T Hassib, Marianne A Mahrouse, Ehab F Elkady, Rawda M Sayed, Simultaneous HPLC Determination of Betamethasone Esters-Containing Mixtures: Analysis of Their Topical Preparations, Journal of Chromatographic Science, Volume 56, Issue 8, September 2018, Pages 716–723, https://doi.org/10.1093/chromsci/bmy047.
8. Mayanka Singh, Manoj S. Charde, Rita M. Charde. RP-HPLC Method for Simultaneous Estimation of Calcipotriene and Betamethasone Dipropionte and Its Combined Dosage Form. Asian J. Research Chem. 4(4): April, 2011; Page 602-606
9. Michael E., Schartz S., Krull., “Analytical Method Development and Validation.”, 2004, 25-46
10. Lloyd R. Snyder., Joseph J. Kirkland., Joseph L. Glajesh., “Practical HPLC Method Development.”, 2nd edition, 1997, 1-14.
11. CIMS – 2006, Current index of medical specialities, pp.172 – 174.
12. Alfred Goodman Gilman, Joel G.Hardaman, Lee E.Limbird, 2001, Goodman Gilman’s The Pharmacological bases of Therapeutics 10th Edn., pp. 994 – 995.
13. Manoj, Shanmugapandiyan.P and Anbazhagans.S, Indian Drugs., 2004; 41, 284 – 289.
14. Beckett H., Stenlake J.B., “Practical Pharmaceutical Chemistry.”, C.B.S. Publications, 4th edition, 1
15. Vijay Malik, “Drugs and Cosmetics Act.”, Eastern Book Company Lucknow, 16th edition, 5.‏